Kanaly Trust’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$31K Buy
341
+66
+24% +$5.69K 0.01% 350
2016
Q3
$23K Hold
275
﹤0.01% 397
2016
Q2
$22K Buy
275
+6
+2% +$457 ﹤0.01% 414
2016
Q1
$19K Sell
269
-42
-14% -$2.82K ﹤0.01% 445
2015
Q4
$22K Sell
311
-10
-3% -$672 ﹤0.01% 413
2015
Q3
$20K Sell
321
-6
-2% -$419 ﹤0.01% 446
2015
Q2
$24K Buy
327
+263
+411% +$19.4K ﹤0.01% 436
2015
Q1
$5K Buy
+64
New +$4.58K ﹤0.01% 511

Other funds holding DGX

Kanaly Trust's DGX Position: Q4 2016 in Review

Kanaly Trust increased its Quest Diagnostics (DGX) stake by 24% in Q4 2016, buying an estimated $5.69K and bringing the position to 341 shares worth $31K. The position accounts for 0.01% of the portfolio, ranked #350.

Kanaly Trust first reported a position in DGX in Q1 2015 and has held it in 8 quarters since. 598 funds tracked by Wall St. Rank hold DGX as of Q4 2016.

  • Kanaly Trust held 341 shares of Quest Diagnostics worth $31K as of Q4 2016.
  • Kanaly Trust bought 66 Quest Diagnostics shares in Q4 2016, an estimated $5.69K.
  • Quest Diagnostics made up 0.01% of Kanaly Trust's portfolio in Q4 2016, its #350 holding.
  • Kanaly Trust first reported a position in Quest Diagnostics in Q1 2015 and has held it in 8 quarters since.
  • 598 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.

Based on Kanaly Trust's 13F filing for Q4 2016, filed 23 Jan 2017.